IL6 and cholangiocarcinoma: Beside S100A6 a prognostic function has also been described for cytokeratin-19 fragments (CYFRA 21-1), IL-6 and microRNA-21, but the available data suggest that panels of more than one biomarker are needed to reliably predict prognosis in patients with CCA [61–63].